| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Tango Therapeutics, Inc.
13G/A
TNGX · 87583X109
|
10.0% |
2/6/2026
Event 12/31/2025
|
||||
| Farallon Capital Partners, L.P. | 1.6% | |||||
| Farallon Capital Institutional Partners, L.P. | 2.2% | |||||
| Farallon Capital Institutional Partners II, L.P. | 0.5% | |||||
| Farallon Capital Institutional Partners III, L.P. | 0.4% | |||||
| Four Crossings Institutional Partners V, L.P. | 0.4% | |||||
| Farallon Capital Offshore Investors II, L.P. | 3.9% | |||||
| Farallon Capital (AM) Investors, L.P. | 0.3% | |||||
| Farallon Capital F5 Master I, L.P. | 0.4% | |||||
| Farallon Healthcare Partners Master, L.P. | 0.2% | |||||
| Farallon Partners, L.L.C. | 9.6% | |||||
| Farallon Institutional (GP) V, L.L.C. | 0.4% | |||||
| Farallon F5 (GP), L.L.C. | 0.4% | |||||
| Farallon Healthcare Partners (GP), L.L.C. | 0.2% | |||||
| Dapice Joshua J. | 10.0% | |||||
| Dreyfuss, Philip D. | 10.0% | |||||
| Dunn Hannah E. | 10.0% | |||||
| Fried, Richard B | 0% | |||||
| Gehani, Varun N. | 10.0% | |||||
| Giauque, Nicolas | 10.0% | |||||
| Husen, Avner A. | 10.0% | |||||
| Kim, David T. | 10.0% | |||||
| Linn, Michael G. | 10.0% | |||||
| Luo Patrick (Cheng) | 10.0% | |||||
| Patel, Rajiv A. | 0% | |||||
| Roberts, Jr., Thomas G. | 10.0% | |||||
| Saito Edric C. | 10.0% | |||||
| Seybold, William | 0% | |||||
| Short Daniel S. | 10.0% | |||||
| Spokes, Andrew J. M. | 10.0% | |||||
| Warren, John R. | 10.0% | |||||
| Wehrly, Mark C. | 10.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.